<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="iso-abbrev">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of substance use and addiction treatment</journal-title></journal-title-group><issn pub-type="ppub">2949-8767</issn><issn pub-type="epub">2949-8759</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10922317</article-id><article-id pub-id-type="pmcid-ver">PMC10922317.319</article-id><article-id pub-id-type="pmcaid">10922317</article-id><article-id pub-id-type="pmcaiid">10922317</article-id><article-id pub-id-type="manuscript-id">NIHMS1950276</article-id><article-id pub-id-type="pmid">37984564</article-id><article-id pub-id-type="doi">10.1016/j.josat.2023.209218</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1950276</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1950276</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Tipping</surname><given-names initials="AD">Andrew D.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nowels</surname><given-names initials="M">Molly</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moore</surname><given-names initials="C">Clara</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Samples</surname><given-names initials="H">Hillary</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Crystal</surname><given-names initials="S">Stephen</given-names></name><xref rid="A2" ref-type="aff">b</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Olfson</surname><given-names initials="M">Mark</given-names></name><xref rid="A4" ref-type="aff">d</xref><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Williams</surname><given-names initials="AR">Arthur Robinson</given-names></name><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Heaps-Woodruff</surname><given-names initials="J">Jodi</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Missouri Institute of Mental Health, University of Missouri &#8211; St. Louis, 1 University Blvd, St. Louis, MO 63121, USA</aff><aff id="A2"><label>b</label>Center for Health Services Research, Institute for Health, Rutgers University, 112 Paterson Street, New Brunswick, NJ 08901, USA</aff><aff id="A3"><label>c</label>School of Social Work, Rutgers University, 536 George Street, New Brunswick, NJ, 08901, USA</aff><aff id="A4"><label>d</label>Vagelos College of Physicians and Surgeons, 630 W 168<sub>th</sub> St, Columbia University, New York, NY 10032, USA</aff><aff id="A5"><label>e</label>Mailman School of Public Health, Columbia University, 722 W 168th St., New York, NY 10032, USA</aff><aff id="A6"><label>f</label>Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Dr., New York, NY 10032, USA</aff><author-notes><corresp id="CR1"><bold>Corresponding author:</bold> Andrew D. Tipping, Research Data Analyst II, Missouri Institute of Mental Health, University of Missouri &#8211; St. Louis, 1 University Blvd., St. Louis, MO 63121, <email>atbr5@umsl.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P57">Conflict of Interest</p><p id="P58">Dr. Williams is the CMO and physician co-founder of Ophelia Health Inc. from which he receives equity, consulting fees, and travel reimbursement. Dr. Samples discloses that she has received consulting fees from the American Society of Addiction Medicine. No other authors have disclosures to report.</p></fn></author-notes><pub-date pub-type="ppub"><month>2</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>19</day><month>11</month><year>2023</year></pub-date><volume>157</volume><issue-id pub-id-type="pmc-issue-id">457420</issue-id><fpage>209218</fpage><lpage>209218</lpage><pub-history><event event-type="nihms-submitted"><date><day>06</day><month>01</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>02</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-01 00:25:38.220"><day>01</day><month>02</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1950276.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P1">Following a nonfatal opioid overdose, patients are at high risk for repeat overdose. The objective of this study was to examine the association of MOUD after nonfatal opioid overdose with risk of repeat overdose in the following year.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">This retrospective cohort study analyzed Missouri Medicaid claims from July 2012 to December 2021. The study identified opioid overdoses occurring between 2013 and 2020 using diagnosis codes for opioid poisoning in an inpatient or emergency department setting. The study implemented Cox models with a time-varying covariate for post-overdose receipt of MOUD.</p></sec><sec id="S3"><title>Results:</title><p id="P3">During the study period, MOUD receipt after overdose more than tripled, from 5.1% to 17%. Overall, only 10.7% of patients received MOUD in the year after index. MOUD during follow-up was associated with significantly lower risk of repeat overdose (HR = 0.24, 95% CI = 0.08&#8211;0.75). Out of 2,962 individuals meeting inclusion criteria, 12.1% had a repeat opioid overdose within 1 year. Repeat overdose risk was more than doubled for those whose index overdose involved heroin or synthetic opioids (HR = 2.1, 95% CI = 1.62&#8211;2.72), but MOUD was associated with significantly reduced risk in this group (HR = 0.21, 95% CI = 0.05&#8211;0.84).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">MOUD receipt was associated with reduced risk of repeat overdose. Those whose index overdoses involved heroin or synthetic opioids were at greater risk of repeat overdose, but MOUD substantially mitigated risk in this group.</p></sec></abstract><kwd-group><kwd>Opioid overdose</kwd><kwd>Opioid use disorder</kwd><kwd>Medication for opioid use disorder</kwd><kwd>Medicaid</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>